MRSA Background. New Challenges From an Old Foe. MRSA Demographics. Comparison of Types of MRSA CA-MRSA HA-MRSA

Size: px
Start display at page:

Download "MRSA Background. New Challenges From an Old Foe. MRSA Demographics. Comparison of Types of MRSA CA-MRSA HA-MRSA"

Transcription

1 Winter Clinical 2017 : MRSA Update Whitney A. High, MD, JD, Meng whitney.high@ucdenver.edu Associate Professor, Dermatology & Pathology Director of Dermatopathology University of Colorado School of Medicine January 2017 Hawaii, Hawaii DISCLOSURE OF RELEVANT RELATIONSHIPS WITH INDUSTRY WHITNEY A. HIGH, MD, JD, MEng MRSA Update I do not have any relevant relationships with industry to disclose. New Challenges From an Old Foe MRSA Background Staph aureus causes most skin and soft tissue infections (SSTI) For decades, Staph aureus was sensitive to dicloxacillin and cephalexin 1961 MRSA first recognized Divided into: hospital acquired (HA-MRSA) community acquired (CA-MRSA) Comparison of Types of MRSA CA-MRSA HA-MRSA Younger patients Older patients MRSA Demographics Countries with highest prevalence of CA-MRSA: United States Japan Skin & soft tissue Isolated β-lactam resistance Often produces exotoxin (PVL) Generally systemic Multidrug resistance Usually no exotoxins Important dates in CA-MRSA history in USA: MRSA outbreak in IVDA in Detroit four fatalities due to CA-MRSA in kids Latter strain (USA300) has come to predominate Saravolatz et al. Ann Intern Med Gardam et al. Can J Infect Dis

2 MRSA American Exceptionalism PVL may be less important, speg may be more important PVL may be less important, speg may be more important Just how common is MRSA? Differs among healthcare settings California ED study (2006) - 59% isolates SSTI Florida OP derm clinic (2008) - 14% isolates SSTI Nashville ED 2001 drained ~150 abscesses/year 2007 drained ~1800 abscesses/year (80% MRSA) 2014 Sentinel Study 6 dermatology centers, 5 states overall incidence of MRSA = 29.4% of isolates CA (38%), TX (33%), AL (31%), AZ (19%), FL (11%) Who gets MRSA? Athletes some of the earliest cases of USA300 were reported in a college football team in Pennsylvania Prisoners other early reports of the same USA300 strain were described in prisoners in Mississippi and California Risk Factors for CA-MRSA Children Athletes Certain ethnic populations MSM & HIV pts IVDA pts Prisoners Military personnel Travelers (you) People in contact with travelers (you) Healthcare workers (you) Recent problems on sports teams across the USA 2

3 Even legal consequences of MRSA January 2016 How CA-MRSA presents? Abscess or furuncle most common Often on extremities (66% on legs) May be mistaken for spider bite May have a surrounding cellulitis Less often: papules and pustules (folliculitis, 7-20%) crusted plaques (impetigo, 3-30%) reports of otitis externa & paronychia Spiders are alleged to do amazing things Real spider bite Real spider bite 24 hours 4 days 24 hours 4 days 3

4 How to treat it! Single abscess may respond to I&D alone cruciate/punch incision, no packing I&D alone cured 87% in one study* (vs. 95%) Still responsive to TMP/SMX, DCN susceptibility to DCN seems durable (~95%/5yr period) Clindamycin resistance (regional, inducible) Consider addition of rifampin (intracellular killing) Decolonization efforts: topical agents, avoid shared soap, towels, towel bars? dilute bleach, BPO soaps, Zn shampoo? Cohen PR, Int J Dermatol. 2007; 46:1-11. Ruhe et al. CID I&D alone probably adequate for most singular abscesses (<5 cm) Packing not typically necessary Systemic antibiotics for those with : multiple lesions rapid disease progression associated cellulitis immunosuppression, extremes of age, or complex medical hx abscess in difficult area (e.g., face, hands, or genitalia) recurrent abscess Notions that patients with larger lesions, surrounding cellulitis, fever, or coexisting conditions particularly benefit from treatment with adjunctive antibiotics are speculative. Tropical MRSA ecthyma 4

5 2.5 year old boy failed 2 courses of cephalexin Community MRSA Blossoming ClindamycinInducible Resistance November 2016 Nature, July 2016 Recognize Complicated Infections Complicating factors: fever, tachycardia, tachypnea, hypotension persons at extremes of age, immunocompromised, etc. may well require intravenous antibiotic Latter may require: vancomycin, daptomycin, linezolid, tedizolid, ceftaroline, dalbavancin, oritavancin, telavancin, and quinupristin-dalfopristin. 5

6 Other Antibiotics for Complicated Infections/Situations Glycopeptides 1 st gen vancomycin 2 nd gen dalbavancin (2 doses a week apart) 2 nd gen - ortavancin (OTD) Oxazolidinones 1 st gen - linezolid (BID, longer course) 2 nd gen - tedizolid (qd, shorter course, side fx) Recurrent Staph Infections In practice, other antibiotics effective for MRSA, and cost less, should be considered first. Why is this a problem? Eradication Therapies Controversial (Cochrane insufficient evidence ) Some % of patients cannot be cleared Oral antibiotics (rifampin/dcn) + topicals Chlorhexidine (P-I, triclosan, tea tree oils) Intranasal mupirocin (BID x 5d) mupirocin resistance on rise (? up to 50%!!!) retapamulin ointment, bacitracin ointment Project CLEAR Allergic Contact Dermatitis From Tea Tree Oil AMBER STONEHOUSE, MD & JAMES STUDDIFORD, MD Consultant. Vol. 47 No. 8 - July 1, 2007 Serial decolonization lasted 6-months, - nasal mupirocin BID, chlorhexidine mouthwash BID, 4% chlorhexidine in shower or bath qd. Researchers found: All comers 30% reduction in MRSA infection 16% reduction in all-cause infection for 1 year Fully compliant 44% reduction in MRSA infection 40% reduction in all-cause infection in 1 year Melaleuca alternifolia Broad antiseptic properties ACD in about 5-10% Cross rxn with benzoin 6

7 Mupirocin Resistance First reported in 1987 (in use since 1985) June 2015, NYC Classically divided into: low-level and high-level resistance thought that high level resistance was rare (2%) Isolated reports of up to 50+% of isolates resistant in some areas Almost certainly related to mupirocin use N=247, May 2012 to September % of isolates resistant to mupirocin Risk factors - MRSA and atopic dermatitis 2014, Houston 9.5% resistance retapamulin 9.8% resistance mupirocin 14% resistance to chlorhexidine Resistance correlated with MRSA status Bleach Baths Had low incidence of MRSA (7.4% skin, 4% nose) There are some theoretical reasons for MSSA predominance in atopic pts. Excellent response with dilute bleach baths and mupirocin ointment to nares 7

8 Prevalence of MRSA in admitted pedi AD patients increased Prevalence of MSSA in admitted pedi AD patients remained stable Important risk factor for MRSA was a previous hospitalization Costs of misdiagnosis... 30% of ED diagnoses of cellulitis were incorrect Costs of $195M to $515M could be avoided Unnecessary exposure to abx November 2016 Prevention of Infection Hand washing is critical to stop MRSA Hand washing compliance in healthcare settings is typically poor 31.4% compliance with hand washing protocol among 13 derms in two clinics Some studies have shown alcohol rubs/gels (60-95%) may be MORE efficacious than handwashing (as practiced) How are we all acquiring and spreading MRSA? The answer may spoil your vacation. Cohen HA et al. Handwashing patterns in two dermatology clinics. Dermatol Basel Switz April hotel rooms, 6 chains 8

9 Staphyloccocus aureus in 34/35 homes MRSA in 9/35 homes Highest predictor of MRSA in home? October 2013 Reversion to MSSA Staphyloccocus aureus in 34/35 homes MRSA in 9/35 homes Highest predictor of MRSA a cat! 10 years 215 patients 30% with one reversion 25% reverted for remainder of the study period Better re-culture with additional episodes! 9

Skin and Soft Tissue Infections Emerging Therapies and 5 things to know

Skin and Soft Tissue Infections Emerging Therapies and 5 things to know 2011 MFMER slide-1 Skin and Soft Tissue Infections Emerging Therapies and 5 things to know Aaron Tande, MD Assistant Professor of Medicine October 27, 2017 Division of INFECTIOUS DISEASES 2011 MFMER slide-2

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL

GUIDE TO INFECTION CONTROL IN THE HOSPITAL GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 43: Staphylococcus Aureus Authors J. Pierce, MD M. Edmond, MD, MPH, MPA M.P. Stevens, MD, MPH Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key

More information

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates What is MRSA? Methicillin-resistant Staphylococus aureus This hardy bacterium has developed resistance to every antibiotic

More information

Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections. Skin & Soft Tissue Infections (SSTI)

Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections. Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections 2007 Abscess Cellulitis Bradley W Frazee, MD, FACEP Dept of Emergency Medicine Alameda County Medical Center - Highland Hospital Associate

More information

Staph Cases. Case #1

Staph Cases. Case #1 Staph Cases Lisa Winston University of California, San Francisco San Francisco General Hospital Case #1 A 60 y.o. man with well controlled HIV and DM presents to clinic with ten days of redness and swelling

More information

Staphylococcus Aureus

Staphylococcus Aureus GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 43: Staphylococcus Aureus Authors J. Pierce, MD M. Edmond, MD, MPH, MPA M.P. Stevens, MD, MPH Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key

More information

Today s Agenda: 9/30/14

Today s Agenda: 9/30/14 Today s Agenda: 9/30/14 1. Students will take C List Medical Abbreviation Quiz. 2. TO: Discuss MRSA. MRSA MRSA Methicillin Resistant Staphylococcus Aureus Methicillin Resistant Staphylococcus Aureus What

More information

Methicillin Resistant Staphylococcus aureus:

Methicillin Resistant Staphylococcus aureus: Methicillin Resistant Staphylococcus aureus: Action-Oriented Guidance for Community-Based Prevention Jackie Dawson, PhD Public Health Epidemiologist Chelan, Douglas, Grant, Kittitas, & Okanogan Counties

More information

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION Effective Date: 04/13/17 Replaces:04/14/16 Page 1 of 7 POLICY To standardize the clinical management and housing of offenders with skin and soft tissue infections, thereby reducing the transmission and

More information

Risk factors? Insect bites? Hygiene? Household crowding Health literacy

Risk factors? Insect bites? Hygiene? Household crowding Health literacy Recurrent boils Commonest sites face, neck, armpits, shoulders, and buttocks (bottom) infection of the hair root or sweat pore Occur in otherwise healthy people (higher rates in diabetics, eczema, iron

More information

Community Methicillin- Resistant Staphylococcus aureus. Sixth Plague of Egypt. Epidemiology

Community Methicillin- Resistant Staphylococcus aureus. Sixth Plague of Egypt. Epidemiology Community Methicillin- Resistant Staphylococcus aureus Henry F. Chambers, M.D. University of California San Francisco San Francisco General Hospital Sixth Plague of Egypt (~ 1200 BCE) So they took soot

More information

Overview Management of Skin and Soft Tissue Infections in the MRSA Era

Overview Management of Skin and Soft Tissue Infections in the MRSA Era Overview Management of Skin and Soft Tissue Infections in the MRSA Era April 2011 2011 IDSA MRSA Treatment Guidelines Skin and soft tissue infections (SSTIs) Management of Recurrent SSTIs Necrotizing soft

More information

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California

More information

Antibiotic Updates: Part I

Antibiotic Updates: Part I Antibiotic Updates: Part I Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

The Bug Stops Here: Treating Resistant Staph Infections Holly Roberts, DVM, MS, DACVD Blue Pearl Veterinary Specialists San Antonio, TX

The Bug Stops Here: Treating Resistant Staph Infections Holly Roberts, DVM, MS, DACVD Blue Pearl Veterinary Specialists San Antonio, TX The Bug Stops Here: Treating Resistant Staph Infections Holly Roberts, DVM, MS, DACVD Blue Pearl Veterinary Specialists San Antonio, TX 1. Staphylococcus bacteria a. Gram positive b. Opportunistic pathogens

More information

S aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium

S aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium S aureus infections: outpatient treatment Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium Intern Med J. 2005 Feb;36(2):142-3 Intern Med J. 2005 Feb;36(2):142-3 Treatment of

More information

Sixth Plague of Egypt. Community MRSA. Epidemiology. Basic Features of Community MRSA. Populations with CA-MRSA

Sixth Plague of Egypt. Community MRSA. Epidemiology. Basic Features of Community MRSA. Populations with CA-MRSA Community MRSA Henry F. Chambers, M.D. University of California San Francisco San Francisco General Hospital Sixth Plague of Egypt (~ 1200 BCE) So they took soot from a kiln, and stood before Pharaoh;

More information

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007 Ca-MRSA Update- Hand Infections Washington Hand Society September 19, 2007 Resistant Staph. Aureus Late 1940 s -50% S.Aureus resistant to PCN 1957-80/81 strain- of S.A. highly virulent and easily transmissible

More information

Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections

Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections 15th Annual Rocky Mountain Hospital Medicine Symposium November 6, 2017 Tim Jenkins, MD Director, Antibiotic Stewardship Program Denver

More information

5/17/2012 DISCLOSURES OBJECTIVES CONTEMPORARY PEDIATRICS

5/17/2012 DISCLOSURES OBJECTIVES CONTEMPORARY PEDIATRICS CONTEMPORARY PEDIATRICS Surgical Management of MRSA Soft Tissue Infections John M. Draus, Jr., M.D. Assistant Professor of Surgery and Pediatrics Kentucky Children s Hospital University of Kentucky DISCLOSURES

More information

Appropriate Antimicrobial Therapy for Treatment of

Appropriate Antimicrobial Therapy for Treatment of Appropriate Antimicrobial Therapy for Treatment of Staphylococcus aureus infections ( MRSA ) By : A. Bojdi MD Assistant Professor Inf. Dis. Dep. Imam Reza Hosp. MUMS Antibiotics Still Miracle Drugs Paul

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 3 PURPOSE To assure that DOP inmates with Soft Tissue Infections are receiving high quality Primary Care for their infections and that the risk of infecting other inmates or staff is minimized.

More information

New Antibiotics & New Insights into Old Antibiotics

New Antibiotics & New Insights into Old Antibiotics New Antibiotics & New Insights into Old Antibiotics Louisiana Chapter of the American Academy of Pediatrics August 18, 2018 Baton Rouge, Louisiana John Bradley MD Rady Children s Hospital San Diego University

More information

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust Neonatal Case History Neonate born at 26 +2 gestation Spontaneous onset of

More information

A. Incision and drainage alone B. Incision and drainage plus oral anti-mrsa antimicrobial agent C. Oral anti-mrsa antimicrobial agent

A. Incision and drainage alone B. Incision and drainage plus oral anti-mrsa antimicrobial agent C. Oral anti-mrsa antimicrobial agent Update: 2011 IDSA MRSA Treatment Guidelines Skin and soft tissue infections (SSTIs) Necrotizing fasciitis Animal bites Other skin and soft tissue infections Catherine Liu, M.D. Assistant Clinical Professor

More information

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members)

Responders as percent of overall members in each category: Practice: Adult 490 (49% of 1009 members) 57 (54% of 106 members) Infectious Diseases Society of America Emerging Infections Network 6/2/10 Report for Query: Perioperative Staphylococcus aureus Screening and Decolonization Overall response rate: 674/1339 (50.3%) physicians

More information

A hypothetical case of nasal microbiome transplantation

A hypothetical case of nasal microbiome transplantation A hypothetical case of nasal microbiome transplantation Katherine P. Lemon, MD, PhD Institute & Boston Children s Hospital Mary-Claire Roghmann, MD, MS University of Maryland Microbiota-transplantation

More information

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses

More information

Infectious Diseases. Disclaimer: Objectives: 2/2/2016. Understanding the problems with sports and the risk of contracting MRSA

Infectious Diseases. Disclaimer: Objectives: 2/2/2016. Understanding the problems with sports and the risk of contracting MRSA Infectious Diseases B.J. Anderson, M.D. Boynton Health Service University of Minnesota 2016 TRIA Orthopedic and Sports Medicine Conference Hockey Injuries: Breaking the Ice February 5-6, 2015 Disclaimer:

More information

Preventing Surgical Site Infections. Edward L. Goodman, MD September 16, 2013

Preventing Surgical Site Infections. Edward L. Goodman, MD September 16, 2013 Preventing Surgical Site Infections Edward L. Goodman, MD September 16, 2013 Outline NHSN Reporting and Definitions Magnitude of the Problem Risk Factors Non Pharmacologic Interventions Pharmacologic Interventions

More information

MRSA Outbreak in Firefighters

MRSA Outbreak in Firefighters MRSA Outbreak in Firefighters Angie Carranza Munger, MD Resident, Occupational and Environmental Medicine The University of Colorado, Denver and National Jewish Health Candidate, Masters of Public Health

More information

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts M R S A Methicillin-Resistant Staphylococcus aureus The Facts Michael Parry, M.D. Director of Infectious Diseases and Microbiology Stamford Hospital January 24, 2008 Introduction to Staph aureus Staphylococcus

More information

Infections caused by Methicillin-Resistant Staphylococcus

Infections caused by Methicillin-Resistant Staphylococcus MRSA infections are no longer limited to hospitals. An infectious disease specialist offers insight on what this means for dermatologists. By Robert S. Jones, DO, Reading, PA Infections caused by Methicillin-Resistant

More information

4/28/11. Update: 2011 IDSA MRSA Treatment Guidelines. Necrotizing fasciitis Animal bites Other skin and soft tissue infections

4/28/11. Update: 2011 IDSA MRSA Treatment Guidelines. Necrotizing fasciitis Animal bites Other skin and soft tissue infections Catherine Liu, M.D. Assistant Clinical Professor Division of Infectious Diseases University of California, San Francisco Update: 2011 IDSA MRSA Treatment Guidelines Skin and soft tissue infections (SSTIs)

More information

Methicillin Resistant Staphylococcus Aureus (MRSA) The drug resistant `Superbug that won t die

Methicillin Resistant Staphylococcus Aureus (MRSA) The drug resistant `Superbug that won t die Methicillin Resistant Staphylococcus Aureus (MRSA) The drug resistant `Superbug that won t die Michael A. Miller, MD Assistant Professor of Pediatrics -Jacksonville OBJECTIVES 1. Understand the basic microbiology

More information

Le infezioni di cute e tessuti molli

Le infezioni di cute e tessuti molli Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections

More information

Tropical infections caused by Staphylococcus aureus

Tropical infections caused by Staphylococcus aureus Tropical infections caused by Staphylococcus aureus Michael Ellis, MD Infectious Diseases Division Uniformed Services University of the Health Sciences February 2015 Introduction Tropical Pyomyositis Cutaneous

More information

TACKLING THE MRSA EPIDEMIC

TACKLING THE MRSA EPIDEMIC TACKLING THE MRSA EPIDEMIC Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine MRSA Trend (HA + CA) in US TSN Database USA (1993-2003) % of MRSA among S. aureus

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

New Antibiotics for MRSA

New Antibiotics for MRSA New Antibiotics for MRSA Faculty Warren S. Joseph, DPM, FIDSA Consultant, Lower Extremity Infectious Diseases Roxborough Memorial Hospital Philadelphia, Pennsylvania Faculty Disclosure Dr. Joseph: Speaker

More information

Discussion Points. Decisions in Selecting Antibiotics

Discussion Points. Decisions in Selecting Antibiotics Antibiotics in Acute Care Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical

More information

CA-MRSA lesions: What works, what doesn t

CA-MRSA lesions: What works, what doesn t For mass reproduction, content licensing and permissions contact Dowden Health Media. FAMILY David McBride, MD University Student Health Services and the Department of Family Medicine, Boston University

More information

22/09/2010. Laboratory 2a + b Staphylococci and Streptococci

22/09/2010. Laboratory 2a + b Staphylococci and Streptococci Laboratory 2a + b Staphylococci and Streptococci 1 Hamster: To be or not to be..!? (a play on Ham-let!) Summary on Exercise 1 (Lab 2a) Big colony heavy growth, color? Double-zone hly CAT and Tube Coag

More information

Annual U.S. ED Visits for Skin and Soft Tissue Infections,

Annual U.S. ED Visits for Skin and Soft Tissue Infections, Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis Animal bites Unusual skin and soft tissue infections Catherine Liu, M.D. Assistant Clinical Professor Division of Infectious

More information

Infectious Disease Update 2017

Infectious Disease Update 2017 Infectious Disease Update 2017 Greg Moran, MD, FACEP, FIDSA Professor of Clinical Emergency Medicine Geffen School of Medicine at UCLA Dept. of Emergency Medicine and Division of Infectious Diseases Olive

More information

Can you treat mrsa with amoxicillin

Can you treat mrsa with amoxicillin Can you treat mrsa with amoxicillin 15-8-2017 Community-associated MRSA You can pick up MRSA outside the hospital, especially if you :. (a related drug developed to treat these germs). Amoxicillin and

More information

Mrsa abscess and cellulitis

Mrsa abscess and cellulitis Search Mrsa abscess and cellulitis An abscess is a collection of pus that has built up within the tissue of the body. Signs and symptoms of abscesses include redness, pain, warmth, and swelling. The. Staph

More information

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass 1

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass   1 Andreas Voss, MD, PhD Professor of Infection Control Radboud University Nijmegen Medical Centre & Canisius-Wilhelmina Hospital Nijmegen, Netherlands Hosted by Dr. Jon O0er Guys & St. Thomas NHS Founda

More information

Optimizing Antibiotic Stewardship in the ED

Optimizing Antibiotic Stewardship in the ED Optimizing Antibiotic Stewardship in the ED Michael Pulia, MD MS FAAEM FACEP Director, UW EM Antibiotic Stewardship Research Program Chair, AAEM Antimicrobial Stewardship Task Force @DrMichaelPulia Learning

More information

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018 Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg

More information

Getting Smart about Skin Infections and MRSA

Getting Smart about Skin Infections and MRSA Getting Smart about Skin Infections and MRSA Loren G. Miller, M.D., M.P.H. Associate Professor of Medicine David Geffen School of Medicine at UCLA Division of Infectious Diseases Director, Infection Control

More information

Bacterial skin infection

Bacterial skin infection D i v i s i o n o f P e d i a t r i c E m e r g e n c y M e d i c i n e P a g e 1 Bacterial skin infection Cellulitis w/o abscess Abscess Deep tissue involvement Multiple abscesses Perirectal Anterior

More information

CELLULITIS / SKIN INFECTIONS

CELLULITIS / SKIN INFECTIONS Skin Infections Assessment Investigations Cellulitis Management Abscess Management Infection Control Antibiotic Choice Education Recurrent Infections Referral to Community Nursing References Skin Infections

More information

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS

COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS COMMUNITY ASSOCIATED METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS A PRACTICAL GUIDE FOR PRIMARY CARE PRACTITIONERS December 21, 2010 Background Since it was first described in 1961 methicillin resistant

More information

Development of Drugs for Skin Infections

Development of Drugs for Skin Infections EFPIA - Skin Infection comments 1 Development of Drugs for Skin Infections John H Rex, MD EFPIA - Skin Infection comments 2 Skin Infections Significant recent debate: Acceptable forms: A focus on fever

More information

Evaluating the Role of MRSA Nasal Swabs

Evaluating the Role of MRSA Nasal Swabs Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization

More information

MRSA What Are Our Treatment Options and How Do We Choose the Right One?

MRSA What Are Our Treatment Options and How Do We Choose the Right One? MRSA What Are Our Treatment Options and How Do We Choose the Right One? Kristi Traugott, PharmD, BCPS Clinical Pharmacy Specialist Infectious Diseases University Health System San Antonio, TX October 25,

More information

Objectives. Impetigo 8/6/2013

Objectives. Impetigo 8/6/2013 Bacterial Infections E.J. Mayeaux, Jr., M.D. Professor of Family Medicine Professor of Obstetrics & Gynecology Louisiana State University Health Sciences Center Shreveport, LA No disclosures to report.

More information

Prevalence & Risk Factors For MRSA. For Vets

Prevalence & Risk Factors For MRSA. For Vets For Vets General Information Staphylococcus aureus is a Gram-positive, aerobic commensal bacterium of humans that is carried in the anterior nares of approximately 30% of the general population. It is

More information

Best Antimicrobials for Staphylococcus aureus Bacteremia

Best Antimicrobials for Staphylococcus aureus Bacteremia Best Antimicrobials for Staphylococcus aureus Bacteremia I. Methicillin Susceptible Staph aureus (MSSA) A. In vitro - Anti-Staphylococcal β-lactams (Oxacillin, Nafcillin, Cefazolin) are more active B.

More information

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials

Disclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site

More information

New Antibiotics & New Insights into Old Antibiotics

New Antibiotics & New Insights into Old Antibiotics New Antibiotics & New Insights into Old Antibiotics Louisiana Chapter of the American Academy of Pediatrics August 18, 2018 Baton Rouge, Louisiana John Bradley MD Rady Children s Hospital San Diego University

More information

Alaska Correctional Officers Association

Alaska Correctional Officers Association Alaska Correctional Officers Association Guidelines for Officers in Preventing Work Place Injury from Electron micrograph of MRSA WALKING ALASKA S TOUGHEST BEAT ALASKA CORRECTIONAL OFFICERS ASSOCIATION

More information

Multi-Drug Resistant Organisms (MDRO)

Multi-Drug Resistant Organisms (MDRO) Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

More information

General Rules Topicals for Skin Infections Topicals for Allergic Skin Disease Topicals for Seborrhea

General Rules Topicals for Skin Infections Topicals for Allergic Skin Disease Topicals for Seborrhea Douglas J. DeBoer, D.V.M., Diplomate A.C.V.D. School of Veterinary Medicine University of Wisconsin-Madison General Rules Topicals for Skin Infections Topicals for Allergic Skin Disease Topicals for Seborrhea

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

Antibiotic Stewardship

Antibiotic Stewardship Antibiotic Stewardship Nick Zaksek Pharm D., BCPS AQ-ID Infectious Disease POMA 2019 1 Disclosures None 2 Objectives Practice good Antibiotic stewardship and foster the notion of antibiotic stewardship

More information

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant Staphylococcus Aureus Skin Infections at a large, urban County Jail System Earl J. Goldstein, MD* Gladys Hradecky, RN* Gary

More information

Antibiotic Updates: Part II

Antibiotic Updates: Part II Antibiotic Updates: Part II Fredrick M. Abrahamian, DO, FACEP, FIDSA Health Sciences Clinical Professor of Emergency Medicine David Geffen School of Medicine at UCLA Los Angeles, California Financial Disclosures

More information

Community Acquired Methicillin Resistant Staphylococcus Aureus

Community Acquired Methicillin Resistant Staphylococcus Aureus Community Acquired Methicillin Resistant Staphylococcus Aureus John S. Hammes, M.D. ABSTRACT Community acquired Methicillin Resistant Staphylococcus aureus (ca-mrsa) is an important cause of illness among

More information

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees.

Conflict of interest: We have no conflict of interest to report on this topic of SSI reduction for total knees. Reducing SSI- Knees TIFFANY KENNERK MBA, MSN, RN, NE -BC, ONC CYNTHIA SEAMAN BSN, RN, ONC, CMSRN ~COMMUNITY HOSPITALS AND WELLNESS CENTERS~ Conflict of interest: We have no conflict of interest to report

More information

Antibiotic Update 2015

Antibiotic Update 2015 Antibiotic Update 2015: Disclosures Antibiotic Update 2015 No Financial Conflicts of Interest Shireesha Dhanireddy, MD 23 April 2015 Current Concepts in Drug Therapy Antibiotic Update 2015: Outline Cystitis

More information

Case: Family D. Staphylococcus aureus. Outline. Staphylococcus aureus Timeline. Newborn Nursery Epidemic: 1950s

Case: Family D. Staphylococcus aureus. Outline. Staphylococcus aureus Timeline. Newborn Nursery Epidemic: 1950s Evolution, Epidemiology, and Eradication of Contemporary Staphylococcus aureus Stephanie Fritz, MD, MSCI Assistant Professor of Pediatrics Washington University School of Medicine September 6, 2012 Case:

More information

Reducing Infections in Surgical Practice. Fred A Sweet, MD Rockford Spine Center Illinois, USA

Reducing Infections in Surgical Practice. Fred A Sweet, MD Rockford Spine Center Illinois, USA Reducing Infections in Surgical Practice Fred A Sweet, MD Rockford Spine Center Illinois, USA Introduction: How bacteria get in The Host The Surgeon The Procedure The STAFF Skin PREP Prophylactic Antibiotics

More information

SASKATCHEWAN REGISTERED NURSES ASSOCIATION. RNs WITH ADDITIONAL AUTHORIZED PRACTICE CLINICAL DECISION TOOL AUGUST 2017

SASKATCHEWAN REGISTERED NURSES ASSOCIATION. RNs WITH ADDITIONAL AUTHORIZED PRACTICE CLINICAL DECISION TOOL AUGUST 2017 DEFINITION Cutaneous infections include: Folliculitis: a superficial inflammation of the epidermis around a hair follicle. This acute lesion usually consists of a dome-shaped pustule at the mouth of the

More information

Practical Management: Community-Associated. methicillin-resistant Staphylococcusaureus (MRSA). The Latest Sports Epidemic

Practical Management: Community-Associated. methicillin-resistant Staphylococcusaureus (MRSA). The Latest Sports Epidemic PRACTICAL MANAGEMENT Practical Management: Community-Associated Methicillin-Resistant Staphylococcus Aureus (CA-MRSA): The Latest Sports Epidemic Holly J. Benjamin, MD,* Vineet Nikore, MD, and Josh Takagishi,

More information

Central Nervous System Infections

Central Nervous System Infections Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY

More information

Source: Portland State University Population Research Center (

Source: Portland State University Population Research Center ( Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:

More information

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare 100% of all wounds will yield growth If you get a negative culture you something is wrong! Pseudomonas while ubiquitous does

More information

SSTI s :A Guideline for Effective Treatment of Skin and Soft Tissue Infections

SSTI s :A Guideline for Effective Treatment of Skin and Soft Tissue Infections SSTI s :A Guideline for Effective Treatment of Skin and Soft Tissue Infections Dr. Javan S. Bass, FACFAS Metro Foot & Ankle Centers, PC Georgia Podiatric Association Board of Directors Disclosures Bako

More information

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT CONTROLLED DOCUMENT Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Guideline Clinical The purpose

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

MRSA Screening (Elective Patients)

MRSA Screening (Elective Patients) What is MRSA? MRSA stands for Meticillin resistant Staphylococcus aureus. It is a type of Staphylococcus aureus bacteria (germ) that is very resistant to antibiotics so infections due to MRSA can be quite

More information

Skin and Soft Tissue Infections

Skin and Soft Tissue Infections GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 28: Skin and Soft Tissue Infections Author Antoni Trilla, MD, PhD, MSc Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Topic Outline Staphylococcal Skin

More information

LINEE GUIDA: VALORI E LIMITI

LINEE GUIDA: VALORI E LIMITI Ferrara 28 novembre 2014 LINEE GUIDA: VALORI E LIMITI Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi EVIDENCE BIASED GERIATRIC MEDICINE Older patients with comorbid conditions

More information

Skin & Soft Tissue Infections (SSTIs)

Skin & Soft Tissue Infections (SSTIs) Skin & Soft Tissue Infections (SSTIs) Marnie Peterson, Pharm.D., Ph.D. College of Pharmacy peter377@umn.edu (612) 626-4388 SSTIs Objectives To classify types of skin infections To present a case of cellulitis

More information

MRSA. ( Staphylococcus aureus; S. aureus ) ( community-associated )

MRSA. ( Staphylococcus aureus; S. aureus ) ( community-associated ) 005 16 190-194 ( Staphylococcus aureus; S. aureus ) ( community-associated ) ( -susceptible Staphylococcus auerus; MSSA ) ( -resistant Staphylococcus auerus; ) ( ) ( -lactam ) ( glycopeptide ) ( Staphylococcus

More information

Antibiotic Use in the Emergency Department

Antibiotic Use in the Emergency Department Antibiotic Use in the Emergency Department Fredrick M. Abrahamian, D.O., FACEP Associate Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA

More information

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antimicrobial stewardship: Quick, don t just do something! Stand there! Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger

More information

5/26/10. Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis Animal bites Unusual skin and soft tissue infections

5/26/10. Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis Animal bites Unusual skin and soft tissue infections Catherine Liu, M.D. Assistant Clinical Professor Division of Infectious Diseases University of California, San Francisco Abscess, cellulitis Recurrent skin and soft tissue infections Necrotizing fasciitis

More information

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Epidemiology of Community- Associated (CA) Methicillin-Resistant Staphylococcus aureus (MRSA) in the United States

Epidemiology of Community- Associated (CA) Methicillin-Resistant Staphylococcus aureus (MRSA) in the United States Epidemiology of Community- Associated (CA) Methicillin-Resistant Staphylococcus aureus (MRSA) in the United States R. M. Klevens, DDS, MPH Division of Healthcare Quality Promotion Acknowledgements CDC

More information

For some reason the skin on the inside of both my nostrils continually splits, heals, and splits again. I do have allergies frequently

For some reason the skin on the inside of both my nostrils continually splits, heals, and splits again. I do have allergies frequently 12-3-2018 For some reason the skin on the inside of both my nostrils continually splits, heals, and splits again. I do have allergies frequently which may contribute. What is Folliculitis? Folliculitis

More information

CA-MRSA: How Should We Respond to Outbreaks?

CA-MRSA: How Should We Respond to Outbreaks? CA-MRSA: How Should We Respond to Outbreaks? Robert B. Stroube, MD, MPH Medscape Infectious Diseases. 2008; 2008 Medscape Posted 11/05/2008 Introduction to MRSA Methicillin-resistant Staphylococcus aureus

More information

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15

HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 HOSPITAL-ACQUIRED INFECTION/MRSA EYERUSALEM KIFLE AND GIFT IMUETINYAN OMOBOGBE PNURSS15 INTRODUCTION DEFINITIONS SIGNS AND SYMPTOMS RISK FACTORS DIAGNOSIS COMPLICATIONS PREVENTIONS TREATMENT PATIENT EDUCATION

More information

Novel therapies & the role of early switch and early discharge protocols for management of MRSA infections

Novel therapies & the role of early switch and early discharge protocols for management of MRSA infections Novel therapies & the role of early switch and early discharge protocols for management of MRSA infections Paul M. Tulkens, MD, PhD Cellular and Molecular Pharmacology & Centre for Clinical Pharmacy Louvain

More information

What s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient

What s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient What s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient Catherine Liu, M.D. Assistant Clinical Professor University of California, San Francisco Overview New

More information

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America

More information